08:00 , Mar 25, 2002 |  BioCentury  |  Strategy

Alkermes buys into specialty pharma

Alkermes Inc.'s acquisition of Reliant Pharmaceuticals LLC checks two boxes in ALKS's bid to become a big cap specialty pharmaceutical company. The deal puts ALKS within spitting distance of the top tier of biotech companies...
08:00 , Mar 25, 2002 |  BioCentury  |  Strategy

Selected products from the combined pipeline of Alkermes and Reliant

Selected products from the combined pipeline of Alkermes and Reliant Product Partner Indication Status Alkermes Nutropin Depot Genentech Growth hormone deficiency Marketed Risperdal Consta Johnson & Johnson Schizophrenia NDA Filed Vivitrex Proprietary Alcoholism Phase...
08:00 , Dec 24, 2001 |  BioCentury  |  Strategy

Investing in the sales channel

A major reason biotech companies partner with pharma is to obtain access to large sales organizations that can address primary care and other broad markets. Alkermes Inc. may have found a different entrée to such...
07:00 , Jul 27, 1998 |  BioCentury  |  Strategy

Heartburn remedies

Heartburn remedies Company Product Mechanism A.H. Robins Reglan gastrointestinal stimulant metoclopramide Eli Lilly Axid nizatidine histamine H2-receptor antagonist Glaxo Wellcome Zantac ranitidine hydrochlorine histamine H2-receptor antagonist Janssen Propulsid cisapridegastrointestinal stimulant Johnson &...